Co-Administration of Seasonal Quadrivalent Influenza and Covid-19 Vaccines Leads to Enhanced Immune Responses to Influenza Virus and Reduced Immune Responses to Sars-Cov-2 in Naive Mice DOI
Anass Abbad,

Joshua Yueh,

Temima Yellin

et al.

Published: Jan. 1, 2024

Language: Английский

Antibody responses in Omicron BF.7-infected patients vaccinated with inactivated SARS-CoV-2 DOI
Yabo Zhao, Weili Li, Liming Xu

et al.

Virology, Journal Year: 2025, Volume and Issue: 603, P. 110404 - 110404

Published: Jan. 11, 2025

Language: Английский

Citations

0

Co-administration of seasonal quadrivalent influenza and COVID-19 vaccines leads to enhanced immune responses to influenza virus and reduced immune responses to SARS-CoV-2 in naive mice DOI
Anass Abbad,

Joshua Yueh,

Temima Yellin

et al.

Vaccine, Journal Year: 2025, Volume and Issue: 50, P. 126825 - 126825

Published: Feb. 7, 2025

Language: Английский

Citations

0

Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic DOI Creative Commons
Luis M. Molinos‐Albert, Rocío Rubio,

Carla Martín-Pérez

et al.

Cell Reports, Journal Year: 2025, Volume and Issue: 44(4), P. 115498 - 115498

Published: April 1, 2025

Immune memory is essential for the effectiveness of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. In current context pandemic, with a diminished vaccine efficacy against emerging variants, it remains crucial to perform long-term studies evaluate durability and quality immune responses. Here, we examined antibody B-cell responses in cohort 113 healthcare workers distinct exposure histories over 3-year period. Previously infected naive participants developed comparable humoral by 17 months after receiving full three-dose mRNA addition, both maintained substantial SARS-CoV-2-reactive pool, associated lower incidence breakthrough infections participants. Of note, previously an expanded CD27-CD21- atypical population that remained stable throughout follow-up Thus, previous SARS-CoV-2 infection differentially imprints compartment without compromising development long-lasting

Language: Английский

Citations

0

In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients DOI Creative Commons

Ilies Benotmane,

Martin Jungbauer-Groznica,

Isabelle Staropoli

et al.

Transplant International, Journal Year: 2024, Volume and Issue: 37

Published: July 16, 2024

LETTER TO THE EDITOR Transpl Int, 16 July 2024 https://doi.org/10.3389/ti.2024.13272

Language: Английский

Citations

1

Co-Administration of Seasonal Quadrivalent Influenza and Covid-19 Vaccines Leads to Enhanced Immune Responses to Influenza Virus and Reduced Immune Responses to Sars-Cov-2 in Naive Mice DOI
Anass Abbad,

Joshua Yueh,

Temima Yellin

et al.

Published: Jan. 1, 2024

Language: Английский

Citations

0